Accretropin
Accretropin™
(somatropin) Injection
DRUG DESCRIPTION
Accretropin™ (recombinant human growth hormone (r-hGH); somatropin) is a protein produced by recombinant DNA technology. It is produced during fermentation in E. coli yielding a protein containing 192 amino acids. The N-terminal amino acid, methionine, is later removed to yield a protein that is chemically and physicochemically identical to pituitary derived human growth hormone, consisting of 191 amino acids in a single polypeptide chain.
Accretropin™ is distributed in a liquid solution containing 1 mL of a 5 mg/mL solution of growth hormone (15 IU/mL). The formulation also contains 0.75% NaCl, 0.34% Phenol (as preservative), 0.2% Pluronic F-68 (a non-ionic surfactant) and is designed for subcutaneous administration. Accretropin™ is stabilized to pH 6.0 with 10 mM NaPO4 buffer.
Generic Name: Somatropin Injection
Rethinking HRT
In 2002, researchers linked estrogen therapy to an increased risk for breast cancer, heart attack and stroke. Now it looks like the hormone is finding its way back into medicine cabinets. See more WebMD Videos »
WebMD Daily
Get breaking medical news.
